SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-307935
Filing Date
2022-12-19
Accepted
2022-12-19 08:42:55
Documents
12
Period of Report
2022-12-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d423141d8k.htm   iXBRL 8-K 43918
  Complete submission text file 0001193125-22-307935.txt   173862

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20221219.xsd EX-101.SCH 2872
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20221219_lab.xml EX-101.LAB 18758
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20221219_pre.xml EX-101.PRE 11725
6 EXTRACTED XBRL INSTANCE DOCUMENT d423141d8k_htm.xml XML 3503
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 221469700
SIC: 2834 Pharmaceutical Preparations